[Tree] Efficacy of TAR-200 Monotherapy in BCG-Unresponsive NMIBC
Version 0.07 (2024-01-05 04:35:09.394000)
updates: New findings on the efficacy of TAR-200 monotherapy in BCG-unresponsive NMIBC
- ➔
Version 0.06 (2023-12-05 18:39:48.581000)
updates: Abbisko out-licenses China rights for pimicotinib to Merck KGaA in $605M deal
- ➔
- ➔
Version 0.05 (2023-12-01 10:50:57.159000)
updates: FDA approval of Toripalimab, Novartis building plant in Zhejiang
- ➔
- ➔
Version 0.04 (2023-11-29 15:32:36.852000)
updates: Chinese cancer drug Toripalimab receives FDA approval with significant price difference
- ➔
Version 0.03 (2023-11-28 07:25:58.987000)
updates: Inclusion of childhood brain cancer treatment breakthrough
- ➔
- ➔
- ➔
- ➔
- ➔
- ➔
- ➔
Version 0.02 (2023-11-14 12:12:39.920000)
updates: Chinese drug approved by FDA for cancer treatment
- ➔
- ➔
- ➔
- ➔
- ➔
- ➔
- ➔
Version 0.01 (2023-11-04 05:08:41.550000)
updates: Added information about Chinese cancer drug approved by FDA
- ➔
- ➔
- ➔
- ➔
- ➔
- ➔